These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27265957)

  • 21. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q; Kim JE; Hyun J; Han KS; Kim HK
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-management of anticoagulation.
    Levi M
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):979-85. PubMed ID: 18666848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Warfarin monitoring: point-of-care INR testing limitations and interpretation of the prothrombin time.
    Jacobson AK
    J Thromb Thrombolysis; 2008 Feb; 25(1):10-1. PubMed ID: 18008039
    [No Abstract]   [Full Text] [Related]  

  • 24. Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration.
    Rosborough TK; Jacobsen JM; Shepherd MF
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):433-5. PubMed ID: 19543077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International normalized ratio in anticoagulant therapy: understanding the issues.
    Severson AL; Baldwin LR; DeLoughery TG
    Am J Crit Care; 1997 Mar; 6(2):88-92; quiz 94. PubMed ID: 9172856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-monitoring for patients on warfarin?
    Drug Ther Bull; 2009 Sep; 47(9):98-101. PubMed ID: 19734191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies.
    Perry SL; Samsa GP; Ortel TL
    Thromb Haemost; 2005 Dec; 94(6):1196-202. PubMed ID: 16411394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Home anticoagulation monitoring is safe and effective.
    Harv Heart Lett; 2000 Dec; 11(4):4-5. PubMed ID: 11114792
    [No Abstract]   [Full Text] [Related]  

  • 29. The economic costs of routine INR monitoring in infants and children--examining point-of-care devices used within the home setting compared to traditional anticoagulation clinic monitoring.
    Gaw JR; Crowley S; Monagle P; Jones S; Newall F
    Thromb Res; 2013 Jul; 132(1):26-31. PubMed ID: 23746471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Home monitoring of warfarin effects.
    Lippi G; Franchini M
    N Engl J Med; 2011 Jan; 364(4):378; author reply 378-9. PubMed ID: 21268733
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessing the utility of an online registry for patients monitoring their own warfarin therapy.
    McCahon D; Baker JM; Murray ET; Fitzmaurice DA
    J Clin Pathol; 2016 Apr; 69(4):331-6. PubMed ID: 26519487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Audit of community-based anticoagulant monitoring in patients with thromboembolic disease: is frequent testing necessary?
    Young L; Ockelford P; Harper P
    Intern Med J; 2004 Nov; 34(11):639-41. PubMed ID: 15546458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiology patient page. Warfarin management: international normalized ratio self-testing and warfarin self-dosing.
    Bussey HI; Bussey M
    Circulation; 2012 Jul; 126(5):e52-4. PubMed ID: 22850365
    [No Abstract]   [Full Text] [Related]  

  • 34. Rethinking warfarin for atrial fibrillation.
    Med Lett Drugs Ther; 2013 Sep; 55(1426):77. PubMed ID: 24081386
    [No Abstract]   [Full Text] [Related]  

  • 35. The 'carry-over' effects of patient self-testing: positive effects on usual care management by an anticoagulation management service.
    Ryan F; O'Shea S; Byrne S
    Thromb Res; 2010 Nov; 126(5):e345-8. PubMed ID: 20828796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring warfarin therapy. How the INR keeps your patient safe.
    Oertel LB
    Nursing; 1999 Nov; 29(11):41-4; quiz 45. PubMed ID: 10633719
    [No Abstract]   [Full Text] [Related]  

  • 37. International sensitivity index calibration of the near-patient testing prothrombin time monitor, ProTime.
    Tripodi A; Chantarangkul V; Bressi C; Mannucci PM
    Am J Clin Pathol; 2003 Feb; 119(2):241-5. PubMed ID: 12579994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of a new method of warfarin management on patient satisfaction, time, and cost.
    Meyer S; Frei CR; Daniels KR; Forcade NA; Bussey M; Bussey-Smith KL; Bussey HI
    Pharmacotherapy; 2013 Nov; 33(11):1147-55. PubMed ID: 24038425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PIVKA-II is a candidate marker for monitoring the effects of the oral anticoagulant warfarin.
    Lee W; Chung HJ; Kim S; Jang S; Park CJ; Chi HS; Chun S; Min WK
    Clin Biochem; 2010 Sep; 43(13-14):1177-9. PubMed ID: 20621074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center.
    Bishop MA; Streiff MB; Ensor CR; Tedford RJ; Russell SD; Ross PA
    ASAIO J; 2014; 60(2):193-8. PubMed ID: 24577370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.